Profile – Dr Sarah Aldous
Post-doctoral research associate at University College London, funded by the UK Dementia Research Institute to research Huntingdon’s Disease. Likes to move it, move it with King Julien XIII.
Post-doctoral research associate at University College London, funded by the UK Dementia Research Institute to research Huntingdon’s Disease. Likes to move it, move it with King Julien XIII.
Orcadian and Reader at the University of Glasgow researching Vascular cognitive impairment, small vessel disease and ischaemic stroke
Research Fellow at the Glasgow Caledonian University, researching the Molecular causes of Alzheimer’s disease. Spending spare time drawing, making, dinosaur digging and going to tea parties!
Postdoc Researcher and a cofounder of One HealthTech, leading the Genomics England Diverse Data initiative to to reduce health inequalities in genomic medicine.
Horse whisperer and Consultant Psychiatrist for Older People and Vice Chair of the Royal College of Psychiatrists Faculty of Old Age Psychiatrist.
PhD Student at the University of Manchester using fruit flies, to investigate the molecular mechanisms that underpin FTD and ALS. Slide-line in animation, bringing Morph back to life!
Axe man, new Dad and Research Associate, currently working on the development and discovery of new drugs to treat neurodegeneration at the UCL ARUK Drug Discovery Institute.
Dementia care consultant and trainer at the Centre for Applied Dementia Studies, University of Bradford with scraped knees and a bag full of records.
Former Head of Research for Alzheimer’s Society now Hub Development Manager for Health Data Research UK
Dr Lucy Stirland is an academic old age psychiatrist at The University of Edinburgh and NHS Lothian studing multimorbidity & dementia
PhD candidate at Newcastle University and Registered Nurse, researching dementia care. Enjoys playing Goldylocks, and isn’t afraid of the bears!
Associate Director, Clinical Development at Eisai working on AD clinical trials from BACE inhibitors to monoclonal antibodies targetting both amyloid and tau.